SEARCH RESULTS FOR: !➧주식DB구합니다◀✅텔레그램thinkDB(9274 results)
The lmmuView® COVID-19 Antigen Home Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus.
This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged two years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.
The lmmuView® COVID-19 Antigen Home Test does not differentiate between SARS-CoV and SARS-CoV-2.
Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen, which is generally detectable in anterior nasal (nares) swab specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with past medical history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Individuals who test positive with the lmmuView® COVID-19 Antigen Home Test should self-isolate and seek follow-up care with their physician or healthcare provider as additional testing may be necessary.
All negative results are presumptive and confirmation with a molecular assay, if necessary for patient management, may be performed. Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control measures such as isolating from others and wearing masks. Negative results should be
CTK BIOTECH INC.
R0182CHT-2T
In Commercial Distribution
- 00855402007955 ()
R0182CHT
- SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing
No Description
IHEALTH LAB INC.
ICO-3000
In Commercial Distribution
- 10856362005903 ()
- 00856362005906 ()
- 20856362005900 ()
- 30856362005907 ()
- SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing
No Description
IHEALTH LAB INC.
ICO-3000
In Commercial Distribution
- 10856362005897 ()
- 00856362005890 ()
- 20856362005894 ()
- 30856362005891 ()
- SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing
FIRST AID KIT - 75 PIECES
Super-Sparkly Safety Stuff, LLC
FA RGLD
In Commercial Distribution
- 00851580004403 ()
- First aid kit, medicated
HEART PROGRAM BAG
CENTURION MEDICAL PRODUCTS CORPORATION
SB1335
In Commercial Distribution
- 50653160089863 ()
- 00653160089868 ()
SB1335
- First aid kit, non-medicated, single-use
No Description
HF ACQUISITION CO. LLC
1018360
1018360
- First aid kit, medicated
No Description
HF ACQUISITION CO. LLC
Criti-Kit Narcan Opioid Overdose Kit
Not in Commercial Distribution
- 00850065007465 ()
1018940
- First aid kit, medicated
No Description
HF ACQUISITION CO. LLC
Criti-Kit 200-AI
In Commercial Distribution
- 00850065007434 ()
1022670
- First aid kit, medicated
No Description
HF ACQUISITION CO. LLC
SM27 SELECT
In Commercial Distribution
- 00850065007427 ()
1018331
- First aid kit, medicated
No Description
HF ACQUISITION CO. LLC
STAT KIT SM7 SELECT
In Commercial Distribution
- 00850065007410 ()
1018351
- First aid kit, medicated